Retrospective Analysis of De-identified Deceased HCC Patients

De-identified deceased HCC patients who were not surgical candidates were evaluated for their clinical baseline characteristics associated with their survival. Baselines included tumor markers, blood counts and liver function tests and CAT-scan based tumor size and numbers and presence of portal vein thrombosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Survival Metatropic dwarfism

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

biopsy-proven HCC

Exclusion criteria

none

Treatment and study plan

Primary outcomes

Survival

Time frame: 10 years

Overall survival

Sponsors and collaborators

Lead sponsor

Carr, Brian

Other

Registry information

Official study title

HCC Observation Study

Important dates

Study start: 1995
Primary completion: 2009
Study completion: 2009
First posted: Jul 20, 2020
Registry last updated: Jul 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed